Data as of Dec 06
| +0.01 / +0.11%|
The 1 analysts offering 12-month price forecasts for Cornerstone Therapeutics Inc have a median target of 9.50, with a high estimate of 9.50 and a low estimate of 9.50. The median estimate represents a -0.11% decrease from the last price of 9.51.
The current consensus among 1 polled investment analysts is to Hold stock in Cornerstone Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.